search
Back to results

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

Primary Purpose

Influenza, COVID-19, RSV Infection

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
(NPS right - Nasal swab left - OPS)
(NPS left - Nasal swab right - OPS)
(Nasal swab right - NPS left - OPS)
(Nasal swab left - NPS right - OPS)
(NPS right - OPS - Nasal swab left)
(NPS left - OPS - Nasal swab right)
(Nasal swab right - OPS - NPS left)
(Nasal swab left - OPS - NPS right)
(OPS - NPS right - Nasal swab left)
(OPS - NPS left - Nasal swab right)
(OPS - Nasal swab left - NPS right)
(OPS - Nasal swab right - NPS left)
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Influenza

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

The inclusion criterion: A. 18 years or more of age requiring a test for COVID-19. The exclusion criteria are : A. Neck breathers (tracheostomy/laryngectomy patients) or other nasopharyngeal or oropharyngeal anomalies that do not allow for sampling using swabs. B. Do not understand oral or written Danish

Sites / Locations

  • Valby COVID19 testcenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm 10

Arm 11

Arm 12

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Sequence for upper airway specimen collection (NPS right - Nasal swab left - OPS)

Sequence for upper airway specimen collection (NPS left - Nasal swab right - OPS)

Sequence for upper airway specimen collection (Nasal swab right - NPS left - OPS)

Sequence for upper airway specimen collection (Nasal swab left - NPS right - OPS)

Sequence for upper airway specimen collection (NPS right - OPS - Nasal swab left)

Sequence for upper airway specimen collection (NPS left - OPS - Nasal swab right)

Sequence for upper airway specimen collection (Nasal swab right - OPS - NPS left)

Sequence for upper airway specimen collection (Nasal swab left - OPS - NPS right)

Sequence for upper airway specimen collection (OPS - NPS right - Nasal swab left)

Sequence for upper airway specimen collection (OPS - NPS left - Nasal swab right)

Sequence for upper airway specimen collection (OPS - Nasal swab left - NPS right)

Sequence for upper airway specimen collection (OPS - Nasal swab right - NPS left)

Arm Description

1 NPS right - Nasal swab left - OPS NPS = nasopharyngeal swab OPS = oropharyngeal swab

2 NPS left - Nasal swab right - OPS

3 Nasal swab right - NPS left - OPS

4 Nasal swab left - NPS right - OPS

5 NPS right - OPS - Nasal swab left

6 NPS left - OPS - Nasal swab right

7 Nasal swab right - OPS - NPS left

8 Nasal swab left - OPS - NPS right

9 OPS - NPS right - Nasal swab left

10 OPS - NPS left - Nasal swab right

11 OPS - Nasal swab left - NPS right

12 OPS - Nasal swab right - NPS left

Outcomes

Primary Outcome Measures

RT-PCR for upper airway viral diagnostics
the detection of nucleic acids from the four most common strains of influenza (B Yamagata, B Victoria, A H1N1 and A H3N2), SARS-CoV-2 and RSV A/B

Secondary Outcome Measures

local immunological mediators from the upper airway tract
measure interferon γ (IFN-γ), C-X-C motif chemokine 10 (CXCL10/IP10), interleukin 10 (IL-10), interleukin 12p70, interleukin 13 (IL-13), interleukin 1β (IL-1β), interleukin 2, interleukin 4 (IL-4), interleukin 5 (IL-5), interleukin 6, CXCL8, tumor necrosis factor α (TNF-α), C-C motif chemokine 5 (CCL5/RANTES), interferon α2a, and granulocyte macrophage colony-stimulating factor (GM-CSF).

Full Information

First Posted
March 1, 2023
Last Updated
March 24, 2023
Sponsor
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT05765838
Brief Title
Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.
Official Title
Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 3, 2023 (Actual)
Primary Completion Date
April 1, 2023 (Anticipated)
Study Completion Date
July 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This is a comparative prospective diagnostic accuracy study reported according to the STARD guidelines. Citizens at an outpatient COVID19 test facility at Testcenter Danmark Valby will be invited to participate in the study on a volunteer basis. The enrolled participants will have the planned oropharyngeal swab performed in the test center and sent for a SARS-CoV-2 RT-PCR test at TestCenter Danmark, Statens Serum Institut, Copenhagen, Denmark as usual. Besides the planned oropharyngeal swab performed in the test center, the participants will have additional specimens collected in form of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs. These will all be used for the detection of nucleic acids from the four most common strains of influenza (B Yamagata, B Victoria, A H1N1 and A H3N2), SARS-CoV-2 and RSV A/B. Further we will measure immune mediating cytokines, chemokines, and interleukins in the different specimens. These analyses will be performed at Technical University of Denmark (DTU).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Influenza, COVID-19, RSV Infection

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
The order of the swabs performed will be decided with randomization to either of the eight combination: NPS right - Nasal swab left - OPS NPS left - Nasal swab right - OPS Nasal swab right - NPS left - OPS Nasal swab left - NPS right - OPS NPS right - OPS - Nasal swab left NPS left - OPS - Nasal swab right Nasal swab right - OPS - NPS left Nasal swab left - OPS - NPS right OPS - NPS right - Nasal swab left OPS - NPS left - Nasal swab right OPS - Nasal swab left - NPS right OPS - Nasal swab right - NPS left
Masking
None (Open Label)
Allocation
Randomized
Enrollment
250 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sequence for upper airway specimen collection (NPS right - Nasal swab left - OPS)
Arm Type
Experimental
Arm Description
1 NPS right - Nasal swab left - OPS NPS = nasopharyngeal swab OPS = oropharyngeal swab
Arm Title
Sequence for upper airway specimen collection (NPS left - Nasal swab right - OPS)
Arm Type
Experimental
Arm Description
2 NPS left - Nasal swab right - OPS
Arm Title
Sequence for upper airway specimen collection (Nasal swab right - NPS left - OPS)
Arm Type
Experimental
Arm Description
3 Nasal swab right - NPS left - OPS
Arm Title
Sequence for upper airway specimen collection (Nasal swab left - NPS right - OPS)
Arm Type
Experimental
Arm Description
4 Nasal swab left - NPS right - OPS
Arm Title
Sequence for upper airway specimen collection (NPS right - OPS - Nasal swab left)
Arm Type
Experimental
Arm Description
5 NPS right - OPS - Nasal swab left
Arm Title
Sequence for upper airway specimen collection (NPS left - OPS - Nasal swab right)
Arm Type
Experimental
Arm Description
6 NPS left - OPS - Nasal swab right
Arm Title
Sequence for upper airway specimen collection (Nasal swab right - OPS - NPS left)
Arm Type
Experimental
Arm Description
7 Nasal swab right - OPS - NPS left
Arm Title
Sequence for upper airway specimen collection (Nasal swab left - OPS - NPS right)
Arm Type
Experimental
Arm Description
8 Nasal swab left - OPS - NPS right
Arm Title
Sequence for upper airway specimen collection (OPS - NPS right - Nasal swab left)
Arm Type
Experimental
Arm Description
9 OPS - NPS right - Nasal swab left
Arm Title
Sequence for upper airway specimen collection (OPS - NPS left - Nasal swab right)
Arm Type
Experimental
Arm Description
10 OPS - NPS left - Nasal swab right
Arm Title
Sequence for upper airway specimen collection (OPS - Nasal swab left - NPS right)
Arm Type
Experimental
Arm Description
11 OPS - Nasal swab left - NPS right
Arm Title
Sequence for upper airway specimen collection (OPS - Nasal swab right - NPS left)
Arm Type
Experimental
Arm Description
12 OPS - Nasal swab right - NPS left
Intervention Type
Diagnostic Test
Intervention Name(s)
(NPS right - Nasal swab left - OPS)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(NPS left - Nasal swab right - OPS)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(Nasal swab right - NPS left - OPS)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(Nasal swab left - NPS right - OPS)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(NPS right - OPS - Nasal swab left)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(NPS left - OPS - Nasal swab right)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(Nasal swab right - OPS - NPS left)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(Nasal swab left - OPS - NPS right)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(OPS - NPS right - Nasal swab left)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(OPS - NPS left - Nasal swab right)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(OPS - Nasal swab left - NPS right)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Intervention Type
Diagnostic Test
Intervention Name(s)
(OPS - Nasal swab right - NPS left)
Intervention Description
Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order
Primary Outcome Measure Information:
Title
RT-PCR for upper airway viral diagnostics
Description
the detection of nucleic acids from the four most common strains of influenza (B Yamagata, B Victoria, A H1N1 and A H3N2), SARS-CoV-2 and RSV A/B
Time Frame
1 day
Secondary Outcome Measure Information:
Title
local immunological mediators from the upper airway tract
Description
measure interferon γ (IFN-γ), C-X-C motif chemokine 10 (CXCL10/IP10), interleukin 10 (IL-10), interleukin 12p70, interleukin 13 (IL-13), interleukin 1β (IL-1β), interleukin 2, interleukin 4 (IL-4), interleukin 5 (IL-5), interleukin 6, CXCL8, tumor necrosis factor α (TNF-α), C-C motif chemokine 5 (CCL5/RANTES), interferon α2a, and granulocyte macrophage colony-stimulating factor (GM-CSF).
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
The inclusion criterion: A. 18 years or more of age requiring a test for COVID-19. The exclusion criteria are : A. Neck breathers (tracheostomy/laryngectomy patients) or other nasopharyngeal or oropharyngeal anomalies that do not allow for sampling using swabs. B. Do not understand oral or written Danish
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tobias Todsen, MD
Phone
+35453545
Email
tobias.todsen@regionh.dk
Facility Information:
Facility Name
Valby COVID19 testcenter
City
Copenhagen
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tobias Gredal

12. IPD Sharing Statement

Plan to Share IPD
Yes

Learn more about this trial

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

We'll reach out to this number within 24 hrs